Osaic Holdings’s Xenetic Biosciences XBIO Stock Holding History

Osaic Holdings’s Portfolio XBIO Stock Details XBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-60	Closed	-$1K	–	7628
2022 Q1	$1K	Hold	60	–	–	﹤0.01%	7133
2021 Q4	$1K	Buy	+60	New	+$957	﹤0.01%	7262
2021 Q3	–	Sell	-500	Closed	-$10K	–	7332
2021 Q2	$10K	Buy	+500	New	+$10.1K	﹤0.01%	6082
2020 Q4	–	Sell	-300	Closed	-$3K	–	6594
2020 Q3	$3K	Buy	+300	New	+$3.24K	﹤0.01%	5769

Other funds holding XBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings's XBIO Position: Q2 2022 in Review

Osaic Holdings sold out of Xenetic Biosciences (XBIO) in Q2 2022, closing a stake of 60 shares — an estimated $1K sold.

Osaic Holdings first reported a position in XBIO in Q3 2020 and held it in 4 quarters. The position peaked at $10K in Q2 2021. 15 funds tracked by Wall St. Rank hold XBIO as of Q2 2022.

Osaic Holdings reported no remaining Xenetic Biosciences position as of Q2 2022 after selling out during the quarter.
Osaic Holdings sold 60 Xenetic Biosciences shares in Q2 2022, an estimated $1K.
Osaic Holdings first reported a position in Xenetic Biosciences in Q3 2020 and held it in 4 quarters.
Osaic Holdings's Xenetic Biosciences position peaked at $10K in Q2 2021.
15 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q2 2022.

Based on Osaic Holdings's 13F filing for Q2 2022, filed 10 Aug 2022.